ZCG-Backed Unimed Acquires Regenboog Shipping Pharmacy

NEW YORK--(BUSINESS WIRE)--Universal Maritime Solutions (“Unimed” or “the Company”), a leading global provider of medical and compliance solutions to the maritime industry, today announced the acquisition of Regenboog Shipping Pharmacy, a Netherlands-based distributor of pharmaceutical products and medical devices serving the maritime sector. Unimed is backed by ZCG Private Equity, the private equity arm of Z Capital Group, LLC (“ZCG”), a privately held global firm.

Based in Rotterdam, Regenboog Shipping Pharmacy has been a trusted partner to the maritime industry since 1989, providing a broad portfolio of pharmaceutical products and medical devices across more than 1,000 SKUs. The business serves more than 300 customers, including ship managers, ship chandlers, and individual vessels operating globally.

“This acquisition represents an important step in our growth strategy, strengthens Unimed’s presence in the Netherlands and builds on the Company’s recent acquisition of Lagaay Medical Group, further expanding Unimed’s scale and capabilities in a core European market. The business brings a strong local presence, deep customer relationships, and a proven operating model. We are pleased to welcome the team to the group and look forward to supporting their continued success while maintaining the high standards of service their customers rely on,” said Adam Pang, Chief Revenue Officer of Unimed.

The transaction reflects Unimed’s broader strategy under ZCG ownership to pursue targeted, locally focused acquisitions that enhance regional coverage and access to operational resources while supporting long-term platform development.

“Unimed’s continued expansion in the Netherlands reflects our long-term approach to building market-leading platforms through disciplined, strategic acquisitions,” said James J. Zenni, Founder, President, and Chief Executive Officer of ZCG. “By investing in businesses with deep local roots and strong customer relationships, we are reinforcing Unimed’s regional leadership and supporting its ability to deliver comprehensive solutions to the global maritime industry.”

About Unimed

Unimed is a leading global provider of medical and compliance solutions to the maritime industry, specializing in the delivery of integrated medical equipment and supplies, healthcare services, and safety supply chain logistical solutions to clients worldwide.

Unimed is a portfolio company of ZCG Private Equity, the private equity arm of ZCG (www.zcg.com), a leading privately held global firm.

For more information, please visit https://universalmarinemedical.com/.

About ZCG

ZCG is a leading, privately held global firm comprised of private markets asset management, business consulting services, and technology development and solutions.

ZCG’s investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.

For almost 30 years, ZCG Principals have invested tens of billions of dollars of capital. ZCG has a global team comprised of approximately 400 professionals. ZCG is headquartered in New York, with seven affiliated offices, across five countries. For more information on ZCG, please visit www.zcg.com.

You can also learn more about ZCGC, the business consulting services platform of ZCG, at www.zcgc.com, and explore ZCG’s technology affiliate, Haptiq, at www.haptiq.com.